Zobrazeno 1 - 10
of 284
pro vyhledávání: '"Julia, Adler"'
Public Health Data Exchange Through Health Information Exchange Organizations: National Survey Study
Publikováno v:
JMIR Public Health and Surveillance, Vol 10, Pp e64969-e64969 (2024)
Abstract BackgroundThe COVID-19 pandemic revealed major gaps in public health agencies’ (PHAs’) data and reporting infrastructure, which limited the ability of public health officials to conduct disease surveillance, particularly among racial or
Externí odkaz:
https://doaj.org/article/51ed55f552b44e7dbf41b549a8d51450
Autor:
Julia Adler-Milstein PhD, Robert Thombley BS, Sarah Rosenthal BA, Benjamin Rosner MD, PhD, Stephanie Rogers MD
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 61 (2024)
While thousands of health systems have begun to implement the Age-Friendly Health System’s 4Ms Framework to improve care for older patients, an important phase of work is achieving consistent adherence to 4Ms care processes. Identifying mechanisms
Externí odkaz:
https://doaj.org/article/836b3d15c3a04aedb5319283ceb3a25d
Publikováno v:
Cells, Vol 13, Iss 19, p 1670 (2024)
A group of intrinsically disordered proteins (IDPs) are subject to 20S proteasomal degradation in a ubiquitin-independent manner. Recently, we have reported that many IDPs/IDRs are targeted to the 20S proteasome via interaction with the C-terminus of
Externí odkaz:
https://doaj.org/article/a09eadb28e234dd7bedad26eef64ebf9
Publikováno v:
Journal of Patient Experience, Vol 11 (2024)
Preparing patients for posthospital care may improve readmission risk. Alternative payment models (APMs) incent hospitals to reduce readmissions by tying payment to outcomes. The impact of APMs on preparation for discharge is not well understood. We
Externí odkaz:
https://doaj.org/article/3444f6b2bc5b4934a4819e9cbb5d9e25
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10781-10790 (2023)
Abstract Background Proteasome inhibitors are in use in treating certain types of cancers. These drugs inhibit the catalytic activity of the 20S proteasome, shared by all the different proteasome complexes. Inhibitors of the 26S‐associated deubiqui
Externí odkaz:
https://doaj.org/article/cefcef473a1e4113b0a1711449776b6d
Publikováno v:
Cancer Medicine, Vol 11, Iss 17, Pp 3296-3303 (2022)
Abstract The rapid adoption of electronic health records (EHRs) has created extensive repositories of digitized data that can be used to inform improvements in care delivery, processes, and patient outcomes. While the clinical data captured in EHRs a
Externí odkaz:
https://doaj.org/article/7dc22c06a72440f0a402eb96609f3cb5
Autor:
Romano Strobelt, Julia Adler, Nir Paran, Yfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, Ziv Shulman, Dominik Schmiedel, Yosef Shaul
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of the COVID-19 pandemic. More than 274 million individuals have suffered from COVID-19 and over five million people have died from this disease so far. The
Externí odkaz:
https://doaj.org/article/a826cd1f56924ec59b2c5a34859e5f55
Publikováno v:
Viruses, Vol 15, Iss 10, p 2124 (2023)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters cells by binding to the angiotensin-converting enzyme 2 (hACE2) receptor. This process is aided by the transmembrane protease serine 2 (TMPRSS2), which enhances entry efficiency
Externí odkaz:
https://doaj.org/article/b1e138db4a294860a5a304cc9cee41f1
Publikováno v:
Biomolecules, Vol 13, Iss 6, p 992 (2023)
Proteasomes critically regulate proteostasis via protein degradation. Proteasomes are multi-subunit complexes composed of the 20S proteolytic core particle (20S CP) that, in association with one or two 19S regulatory particles (19S RPs), generates th
Externí odkaz:
https://doaj.org/article/69aced5f08054100b7a8237b9497d418
Publikováno v:
Viruses, Vol 15, Iss 5, p 1129 (2023)
The COVID-19 pandemic resulted from the global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its first appearance in 2019, new SARS-CoV-2 variants of concern (VOCs) have emerged frequently, changing the infection
Externí odkaz:
https://doaj.org/article/7f5a2db4666d4884b6adeaa363e779da